FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2768762632> ?p ?o ?g. }

• W2768762632 endingPage "210" @default.
• W2768762632 startingPage "198" @default.
• W2768762632 abstract "Cardiac contractile function is adenosine-5'-triphosphate (ATP)-intensive, and the myocardium’s high demand for oxygen and energy substrates leaves it acutely vulnerable to interruptions in its blood supply. The myriad cardioprotective properties of the natural intermediary metabolite pyruvate make it a potentially powerful intervention against the complex injury cascade ignited by myocardial ischemia–reperfusion. A readily oxidized metabolic substrate, pyruvate augments myocardial free energy of ATP hydrolysis to a greater extent than the physiological fuels glucose, lactate and fatty acids, particularly when it is provided at supra-physiological plasma concentrations. Pyruvate also exerts antioxidant effects by detoxifying reactive oxygen and nitrogen intermediates, and by increasing nicotinamide adenine dinucleotide phosphate reduced form (NADPH) production to maintain glutathione redox state. These enhancements of free energy and antioxidant defenses combine to augment sarcoplasmic reticular Ca 2+ release and re-uptake central to cardiac mechanical performance and to restore β-adrenergic signaling of ischemically stunned myocardium. By minimizing Ca 2+ mismanagement and oxidative stress, pyruvate suppresses inflammation in post-ischemic myocardium. Thus, pyruvate administration stabilized cardiac performance, augmented free energy of ATP hydrolysis and glutathione redox systems, and/or quelled inflammation in a porcine model of cardiopulmonary bypass, a canine model of cardiac arrest–resuscitation, and a caprine model of hypovolemia and hindlimb ischemia–reperfusion. Pyruvate’s myriad benefits in preclinical models provide the mechanistic framework for its clinical application as metabolic support for myocardium at risk. Phase one trials have demonstrated pyruvate’s safety and efficacy for intravenous resuscitation for septic shock, intracoronary infusion for heart failure and as a component of cardioplegia for cardiopulmonary bypass. The favorable outcomes of these trials, which argue for expanded, phase three investigations of pyruvate therapy, mirror findings in isolated, perfused hearts, underscoring the pivotal role of preclinical research in identifying clinical interventions for cardiovascular diseases. Impact statement This article reviews pyruvate’s cardioprotective properties as an energy-yielding metabolic fuel, antioxidant and anti-inflammatory agent in mammalian myocardium. Preclinical research has shown these properties make pyruvate a powerful intervention to curb the complex injury cascade ignited by ischemia and reperfusion. In ischemically stunned isolated hearts and in large mammal models of cardiopulmonary bypass, cardiac arrest–resuscitation and hypovolemia, intracoronary pyruvate supports recovery of myocardial contractile function, intracellular Ca 2+ homeostasis and free energy of ATP hydrolysis, and its antioxidant actions restore β-adrenergic signaling and suppress inflammation. The first clinical trials of pyruvate for cardiopulmonary bypass, fluid resuscitation and intracoronary intervention for congestive heart failure have been reported. Receiver operating characteristic analyses show remarkable concordance between pyruvate’s beneficial functional and metabolic effects in isolated, perfused hearts and in patients recovering from cardiopulmonary bypass in which they received pyruvate- vs. L-lactate-fortified cardioplegia. This research exemplifies the translation of mechanism-oriented preclinical studies to clinical application and outcomes." @default.
• W2768762632 created "2017-12-04" @default.
• W2768762632 creator A5024195337 @default.
• W2768762632 creator A5026676194 @default.
• W2768762632 creator A5074682486 @default.
• W2768762632 date "2017-11-20" @default.
• W2768762632 modified "2023-09-24" @default.
• W2768762632 title "Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application" @default.
• W2768762632 cites W105678245 @default.
• W2768762632 cites W111830277 @default.
• W2768762632 cites W1437209072 @default.
• W2768762632 cites W1489262505 @default.
• W2768762632 cites W1507659964 @default.
• W2768762632 cites W1527207562 @default.
• W2768762632 cites W15590391 @default.
• W2768762632 cites W1586233686 @default.
• W2768762632 cites W1675225715 @default.
• W2768762632 cites W1693234450 @default.
• W2768762632 cites W1753393634 @default.
• W2768762632 cites W1790261501 @default.
• W2768762632 cites W1858301031 @default.
• W2768762632 cites W1964394222 @default.
• W2768762632 cites W1964815111 @default.
• W2768762632 cites W1968567514 @default.
• W2768762632 cites W1969649414 @default.
• W2768762632 cites W1969881609 @default.
• W2768762632 cites W1970588833 @default.
• W2768762632 cites W1971001121 @default.
• W2768762632 cites W1975331470 @default.
• W2768762632 cites W1975841960 @default.
• W2768762632 cites W1976499274 @default.
• W2768762632 cites W1977844337 @default.
• W2768762632 cites W1978006498 @default.
• W2768762632 cites W1980895281 @default.
• W2768762632 cites W1981913094 @default.
• W2768762632 cites W1982317185 @default.
• W2768762632 cites W1982370712 @default.
• W2768762632 cites W1986089152 @default.
• W2768762632 cites W1986299008 @default.
• W2768762632 cites W1986816642 @default.
• W2768762632 cites W1987041864 @default.
• W2768762632 cites W1987399715 @default.
• W2768762632 cites W1989324891 @default.
• W2768762632 cites W1995349920 @default.
• W2768762632 cites W1997113286 @default.
• W2768762632 cites W1998404324 @default.
• W2768762632 cites W2000312297 @default.
• W2768762632 cites W2001301496 @default.
• W2768762632 cites W2003081449 @default.
• W2768762632 cites W2006071625 @default.
• W2768762632 cites W2007600141 @default.
• W2768762632 cites W2007607699 @default.
• W2768762632 cites W2011348831 @default.
• W2768762632 cites W2013187795 @default.
• W2768762632 cites W2013723651 @default.
• W2768762632 cites W2016584191 @default.
• W2768762632 cites W2019950737 @default.
• W2768762632 cites W2020095523 @default.
• W2768762632 cites W2021326018 @default.
• W2768762632 cites W2026798193 @default.
• W2768762632 cites W2030629436 @default.
• W2768762632 cites W2030989730 @default.
• W2768762632 cites W2036227941 @default.
• W2768762632 cites W2037222324 @default.
• W2768762632 cites W20380625 @default.
• W2768762632 cites W2039053852 @default.
• W2768762632 cites W2040704590 @default.
• W2768762632 cites W2041634380 @default.
• W2768762632 cites W2042367750 @default.
• W2768762632 cites W2043836507 @default.
• W2768762632 cites W2046099359 @default.
• W2768762632 cites W2050087783 @default.
• W2768762632 cites W2055343900 @default.
• W2768762632 cites W2056180828 @default.
• W2768762632 cites W2057842040 @default.
• W2768762632 cites W2059754724 @default.
• W2768762632 cites W2061322084 @default.
• W2768762632 cites W2065320565 @default.
• W2768762632 cites W2065795681 @default.
• W2768762632 cites W2067271417 @default.
• W2768762632 cites W2068209238 @default.
• W2768762632 cites W2068633686 @default.
• W2768762632 cites W2069670534 @default.
• W2768762632 cites W2071679468 @default.
• W2768762632 cites W2071801519 @default.
• W2768762632 cites W2072219226 @default.
• W2768762632 cites W2072268646 @default.
• W2768762632 cites W2072581962 @default.
• W2768762632 cites W2075575581 @default.
• W2768762632 cites W2076122670 @default.
• W2768762632 cites W2076127324 @default.
• W2768762632 cites W2077640018 @default.
• W2768762632 cites W2079455119 @default.
• W2768762632 cites W2080869214 @default.
• W2768762632 cites W2084596153 @default.
• W2768762632 cites W2085033819 @default.
• W2768762632 cites W2086017163 @default.
• W2768762632 cites W2087429709 @default.

• next